These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. Hillman L; Gottfried M; Whitsett M; Rakela J; Schilsky M; Lee WM; Ganger D Am J Gastroenterol; 2016 Jul; 111(7):958-65. PubMed ID: 27045922 [TBL] [Abstract][Full Text] [Related]
26. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470 [TBL] [Abstract][Full Text] [Related]
27. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. Björnsson E; Jacobsen EI; Kalaitzakis E J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469 [TBL] [Abstract][Full Text] [Related]
28. Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience. Ghabril M; Fontana R; Rockey D; Jiezhun G; Chalasani N J Clin Gastroenterol; 2013 Jul; 47(6):553-8. PubMed ID: 23388845 [TBL] [Abstract][Full Text] [Related]
29. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359 [TBL] [Abstract][Full Text] [Related]
30. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center. Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobials and Antiepileptics Are the Leading Causes of Idiosyncratic Drug-induced Liver Injury in American Children. DiPaola F; Molleston JP; Gu J; Cirulli ET; Chalasani N; Barnhart H; Kleiner DE; Hoofnagle JH; Fontana RJ; J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):152-159. PubMed ID: 31169665 [TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Conlon C; Li YJ; Ahmad J; Barnhart H; Fontana RJ; Ghabril M; Hayashi PH; Kleiner DE; Lee WM; Navarro V; Odin JA; Phillips EJ; Stolz A; Vuppalanchi R; Halegoua-DeMarzio D; Aliment Pharmacol Ther; 2024 Sep; 60(6):787-795. PubMed ID: 38988034 [TBL] [Abstract][Full Text] [Related]
33. Liver injury from nonsteroidal anti-inflammatory drugs in the United States. Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW; Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797 [TBL] [Abstract][Full Text] [Related]
34. Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients. Kowalec K; Kingwell E; Yoshida EM; Marrie RA; Kremenchutzky M; Campbell TL; Wadelius M; Carleton B; Tremlett H Expert Opin Drug Saf; 2014 Oct; 13(10):1305-17. PubMed ID: 25134421 [TBL] [Abstract][Full Text] [Related]
35. Drug- and herb-induced liver injury: a case series from a single center. Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129 [TBL] [Abstract][Full Text] [Related]
36. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system. Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417 [TBL] [Abstract][Full Text] [Related]
37. Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome. Vuppalanchi R; Gotur R; Reddy KR; Fontana RJ; Ghabril M; Kosinski AS; Gu J; Serrano J; Chalasani N Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1550-5. PubMed ID: 24362054 [TBL] [Abstract][Full Text] [Related]
38. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Lucena MI; Andrade RJ; Kaplowitz N; García-Cortes M; Fernández MC; Romero-Gomez M; Bruguera M; Hallal H; Robles-Diaz M; Rodriguez-González JF; Navarro JM; Salmeron J; Martinez-Odriozola P; Pérez-Alvarez R; Borraz Y; Hidalgo R; Hepatology; 2009 Jun; 49(6):2001-9. PubMed ID: 19475693 [TBL] [Abstract][Full Text] [Related]
39. Idiosyncratic Drug-Induced Liver Injury Associated With and Without Drug Reaction With Eosinophilia and Systemic Symptoms. Devarbhavi H; Kurien SS; Raj S; Patil M; Gowda V; Kothari K; Singh R Am J Gastroenterol; 2022 Oct; 117(10):1709-1713. PubMed ID: 35862835 [TBL] [Abstract][Full Text] [Related]